Harvey v. Commissioner of Social Security

CourtDistrict Court, S.D. Ohio
DecidedAugust 25, 2023
Docket3:22-cv-00340
StatusUnknown

This text of Harvey v. Commissioner of Social Security (Harvey v. Commissioner of Social Security) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Harvey v. Commissioner of Social Security, (S.D. Ohio 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF OHIO WESTERN DIVISION

SHELIA H.,

Plaintiff, v. Civil Action 3:22-cv-340 Judge Michael J. Newman Magistrate Judge Kimberly A. Jolson

COMMISSIONER OF SOCIAL SECURITY,

Defendant.

REPORT AND RECOMMENDATION Plaintiff, Shelia H., brings this action under 42 U.S.C. § 405(g) seeking review of a final decision of the Commissioner of Social Security (“Commissioner”) denying her applications for Disability Insurance Benefits (“DIB”) and Supplemental Security Income (“SSI”). For the following reasons, it is RECOMMENDED that the Court REVERSE the Commissioner of Social Security’s nondisability finding and REMAND this case to the Commissioner and the ALJ under Sentence Four of § 405(g). I. BACKGROUND In September 2018, Plaintiff protectively filed her applications for DIB and SSI, alleging that she was disabled beginning December 7, 2017, due to seizures, stress, COPD, emphysema, risk for falling, severe headaches, depression, anxiety, subarachnoid hemorrhage, cutaneous abscess of back excluding buttock, chronic bronchitis, tumors, back problems, insomnia, sexual assault, pelvic pain, right foot goes inward, hemisensory defect, abnormality of gait, gout abscess, and rheumatoid arthritis. (R. at 360–65, 366–70, 388). After her applications were denied initially and on reconsideration, the Administrative Law Judge (the “ALJ”) held a hearing. (R. at 83–124). Ultimately, the ALJ denied Plaintiff’s applications in a written decision on October 20, 2021. (R. at 14–43). When the Appeals Council denied review, that denial became the final decision of the Commissioner. (R. at 1–8). Next, Plaintiff brought this action. (Doc. 1). As required, the Commissioner filed the administrative record, and the matter has been fully briefed. (Docs. 10, 11, 12, 13).

A. Relevant Hearing Testimony The ALJ summarized Plaintiff’s hearing testimony as follows: [Plaintiff] testified she is separated and lives in a house with her daughter. She is unable to work for both physical and mental reasons. Physically, [Plaintiff] has at least 4 seizures a month triggered by flashing lights and hot/humid weather resulting in daily headaches, balance issues, and tremors. She uses supplemental Oxygen for 3 hours when going outside and at night for COPD symptoms that are aggravated by chemicals. She smokes cigarettes. She also has hand pain from carpal tunnel syndrome and can lift no more than 5 pounds. [Plaintiff] uses a cane every day and a walker in her house due to back pain that radiates to the right leg and interferes with sleep. Right footwear is limited to flip flops so she can walk no longer than 20 yards and has a “handicap” placard. However, she has not sought further treatment beyond medication that causes sedation because of COVID.

As for her mental health, [Plaintiff] stated she has a history of bipolar disorder and those symptoms consist of mood swings, anger outbursts, anxiety, social isolation, and depression.

(R. at 20–21).

B. Relevant Medical History The ALJ summarized Plaintiff’s medical records as to her relevant physical impairments as follows: [Plaintiff]’s primary physical impairment is a history of COPD alternatively diagnosed throughout the record as asthma (Exhibits B4F / B5F / B6F / B22F / B33F / B39F). Her respiratory complaints, for which she uses a nebulizing machine (Exhibit B18E), are significant. Spirometric testing performed in September 2019 showed FVC and FEV readings which represented 65% and 50% of predicted values after administration of bronchodilation, respectively (Exhibits B14F / B18F) representing “severe” obstruction (Exhibit B14F at 6).

Supplemental oxygen was prescribed by [Plaintiff]’s pulmonologist in September 2017, but only for nocturnal use (Exhibit B39F at 31). Dr. Yacoub then prescribed supplemental portable oxygen in November 2018 (Exhibit B39F at 44), but that was in response to an exacerbation of [Plaintiff]’s respiratory symptoms (Exhibit B39F at 57). Otherwise, flares of symptoms have been treated conservatively on an outpatient basis with treatment typically consisting of a course of antibiotics and a dose of steroids as well as medications (Exhibits B4F at 11, 21, 58/B22F/B23F/B33F/B39F at 57). Smoking cessation also has been advised on multiple treatment occasions (see, e.g. Exhibits B36F / B39F).

Medical records indicate that there was an incident in the past in August 2016 when [Plaintiff] suffered head trauma secondary to a convulsive event when she struck her head on concrete (Exhibit B4F at 143). Since that time, she has been followed by neurology (Exhibit B4F at 226-227) and podiatry (Exhibit B1F) and alleges various residuals including right foot drop (Exhibit B26F), migraine headaches, neurocognitive deficits, some further seizure activity (Exhibit B4F at 143, 202, 211) and frequent falls requiring the use of a quad-based cane and four-wheeled walker for ambulation (Exhibits B1F at 9 / B4F at 52 / B31F at 16 / B18E). [Plaintiff] has had a series of ER visits for breakthrough seizures and associated headaches (Exhibits B4F at 39, 79, 225) and was admitted on one occasion in September 2018 for an acute exacerbation of chronic headaches and seizure disorder (Exhibit B4F at 47). There is some question about [Plaintiff]’s anticonvulsant medication compliance (Exhibit B4F at 79). Nevertheless, there has been no acute pathology to account for [Plaintiff]’s symptoms and lab work has been without significant abnormality (Exhibit B4F at 39, 47). CT scans and imaging of [Plaintiff]’s head and cervical spine have been nonacute (Exhibits B4F at 62, 238, 260, 266, 272). Beyond evidence of “mild” generalized encephalopathy, EEG testing also has been negative (Exhibit B4F at 62, 235). [Plaintiff] does have a “higher risk of seizures” due to her past subarachnoid hemorrhage (SAH)/subdural hematoma (SDH), and as such, continues anticonvulsant medication treatment (Exhibits B4F /B5F). But, her seizure episodes have been described from a neurological standpoint as “most consistent with non epileptic events” (Exhibit B4F at 196), and she has been referred by neurology for counseling and treatment of anxiety and depression and probable somatization or conversion (Exhibit B4F at 176).

(R. at 21–22).

C. Medical Opinions The ALJ summarized and evaluated the medical opinions pertaining to plaintiff’s physical impairments as follows: [Plaintiff]’s neurologist, Barbara Phillips, M.D., submitted an assessment of her physical functioning capabilities in September 2017 (Exhibit B30F). But, beyond offering diagnoses of transient alteration of awareness, tremors, and headaches, Dr. Phillips’ opinion evidence is incomplete even noting that functional limitations are not evaluated in the scope of her practice. As such, her opinion evidence is not persuasive. Dr. Yacoub submitted an assessment of [Plaintiff]’s physical capabilities in May 2021 (Exhibits B34F / B38F). He indicated that [Plaintiff] can/lift carry just 5 pounds and that her ability to stand/walk and sit was limited but offered no indication as to what extent. In any event, the pulmonary function testing of record does not warrant this level of lifting limitation especially given that chest x-rays have shown no active cardiopulmonary disease (Exhibits B4F at 299, 300 / B22F at 17) and physical examination findings reveal normal breath sounds with no respiratory distress or wheezing (Exhibits B4F / B17F/ B21F / B23F / B25F).

Other opinion evidence in the record includes the findings of Dr. Oza who consultatively examined [Plaintiff] on February 26, 2019 *** (Exhibit B8F).

Dr. Oza diagnosed residual right-sided weakness, a speech impairment, and a seizure disorder stable on an anticonvulsant (Keppra).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Harvey v. Commissioner of Social Security, Counsel Stack Legal Research, https://law.counselstack.com/opinion/harvey-v-commissioner-of-social-security-ohsd-2023.